241 related articles for article (PubMed ID: 30115470)
1. Survival impact and toxicity of metformin in head and neck cancer: An analysis of the SEER-Medicare dataset.
Stokes WA; Eguchi M; Amini A; Hararah MK; Ding D; McDermott JD; Bradley CJ; Karam SD
Oral Oncol; 2018 Sep; 84():12-19. PubMed ID: 30115470
[TBL] [Abstract][Full Text] [Related]
2. Statin use associated with improved overall and cancer specific survival in patients with head and neck cancer.
Gupta A; Stokes W; Eguchi M; Hararah M; Amini A; Mueller A; Morgan R; Bradley C; Raben D; McDermott J; Karam SD
Oral Oncol; 2019 Mar; 90():54-66. PubMed ID: 30846177
[TBL] [Abstract][Full Text] [Related]
3. Metformin exposure and survival in head and neck cancer: A large population-based cohort study.
Alcusky M; Keith SW; Karagiannis T; Rabinowitz C; Louis DZ; Maio V
J Clin Pharm Ther; 2019 Aug; 44(4):588-594. PubMed ID: 31293011
[TBL] [Abstract][Full Text] [Related]
4. Diabetes mellitus, metformin and head and neck cancer.
Figueiredo RA; Weiderpass E; Tajara EH; Ström P; Carvalho AL; de Carvalho MB; Kanda JL; Moyses RA; Wünsch-Filho V
Oral Oncol; 2016 Oct; 61():47-54. PubMed ID: 27688104
[TBL] [Abstract][Full Text] [Related]
5. Sarcomatoid Carcinoma in the Head and Neck: A Population-Based Analysis of Outcome and Survival.
Ding L; Bi ZF; Yuan H; Zhao XH; Guan XD; Yao HR; Liu YM
Laryngoscope; 2021 Feb; 131(2):E489-E499. PubMed ID: 33135805
[TBL] [Abstract][Full Text] [Related]
6. Effect of metformin on the incidence of head and neck cancer in diabetics.
Yen YC; Lin C; Lin SW; Lin YS; Weng SF
Head Neck; 2015 Sep; 37(9):1268-73. PubMed ID: 24801563
[TBL] [Abstract][Full Text] [Related]
7. Does metformin usage improve survival in head and neck squamous cell carcinoma? A population-based study.
Quimby AE; Lebo NL; Griffiths R; Hall S; Dimitroulakos J; Johnson-Obaseki S
J Otolaryngol Head Neck Surg; 2018 Dec; 47(1):74. PubMed ID: 30514404
[TBL] [Abstract][Full Text] [Related]
8. Definitive radiation with concurrent cetuximab vs. radiation with or without concurrent cytotoxic chemotherapy in older patients with squamous cell carcinoma of the head and neck: Analysis of the SEER-medicare linked database.
Zandberg DP; Cullen K; Bentzen SM; Goloubeva OG
Oral Oncol; 2018 Nov; 86():132-140. PubMed ID: 30409293
[TBL] [Abstract][Full Text] [Related]
9. Improved survival using intensity-modulated radiation therapy in head and neck cancers: a SEER-Medicare analysis.
Beadle BM; Liao KP; Elting LS; Buchholz TA; Ang KK; Garden AS; Guadagnolo BA
Cancer; 2014 Mar; 120(5):702-10. PubMed ID: 24421077
[TBL] [Abstract][Full Text] [Related]
10. A Comparison of the NCDB and SEER Database for Research Involving Head and Neck Cancer.
Janz TA; Graboyes EM; Nguyen SA; Ellis MA; Neskey DM; Harruff EE; Lentsch EJ
Otolaryngol Head Neck Surg; 2019 Feb; 160(2):284-294. PubMed ID: 30129822
[TBL] [Abstract][Full Text] [Related]
11. Impact of metformin on disease control and survival in patients with head and neck cancer: a retrospective cohort study.
Lee DJ; McMullen CP; Foreman A; Huang SH; Lu L; Xu W; de Almeida JR; Liu G; Bratman SV; Goldstein DP
J Otolaryngol Head Neck Surg; 2019 Jul; 48(1):34. PubMed ID: 31345259
[TBL] [Abstract][Full Text] [Related]
12. Survival Benefit from Cancer-Directed Surgery for Metastatic Head and Neck Cancer.
Zhu R; Zhu H
Laryngoscope; 2024 Mar; 134(3):1288-1298. PubMed ID: 37658720
[TBL] [Abstract][Full Text] [Related]
13. Effect of metformin on progression of head and neck cancers, occurrence of second primary cancers, and cause-specific survival.
Kwon M; Roh JL; Song J; Lee SW; Kim SB; Choi SH; Nam SY
Oncologist; 2015 May; 20(5):546-53. PubMed ID: 25802404
[TBL] [Abstract][Full Text] [Related]
14. Metformin Prevents the Progression of Dysplastic Mucosa of the Head and Neck to Carcinoma in Nondiabetic Patients.
Lerner MZ; Mor N; Paek H; Blitzer A; Strome M
Ann Otol Rhinol Laryngol; 2017 Apr; 126(4):340-343. PubMed ID: 28103701
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Comorbidities among Older Head and Neck Cancer Survivors in the United States.
Eytan DF; Blackford AL; Eisele DW; Fakhry C
Otolaryngol Head Neck Surg; 2019 Jan; 160(1):85-92. PubMed ID: 30252608
[TBL] [Abstract][Full Text] [Related]
16. A SEER-Medicare analysis of the impact of metformin on overall survival in ovarian cancer.
Garcia C; Yao A; Camacho F; Balkrishnan R; Cantrell LA
Gynecol Oncol; 2017 Aug; 146(2):346-350. PubMed ID: 28499649
[TBL] [Abstract][Full Text] [Related]
17. Survival of patients with stage IV lung cancer with diabetes treated with metformin.
Lin JJ; Gallagher EJ; Sigel K; Mhango G; Galsky MD; Smith CB; LeRoith D; Wisnivesky JP
Am J Respir Crit Care Med; 2015 Feb; 191(4):448-54. PubMed ID: 25522257
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of metformin, statins and anti-inflammatory drugs on head and neck cancer: A systematic review.
Saka Herrán C; Jané-Salas E; Estrugo Devesa A; López-López J
Oral Oncol; 2018 Oct; 85():68-81. PubMed ID: 30220322
[TBL] [Abstract][Full Text] [Related]
19. Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age.
Chen MM; Colevas AD; Megwalu U; Divi V
Oral Oncol; 2018 Sep; 84():71-75. PubMed ID: 30115479
[TBL] [Abstract][Full Text] [Related]
20. Metformin Improves Survival in Patients with Pancreatic Ductal Adenocarcinoma and Pre-Existing Diabetes: A Propensity Score Analysis.
Amin S; Mhango G; Lin J; Aronson A; Wisnivesky J; Boffetta P; Lucas AL
Am J Gastroenterol; 2016 Sep; 111(9):1350-7. PubMed ID: 27430290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
